Cardiology
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genetics
Geriatrics/Aging
Hematology/Oncology
Immunology/Allergy
Infectious Disease
Nephrology
Neurology/Neurosurgery
Obstetrics/Gynecology
Pediatrics
Psychiatry
Public Health, Policy, and Training
Pulmonary
Rheumatology
Surgery

Nejm News Une Mise à Jour The New England Journal of Medicine by Specialties

 


The New England Journal of Medicine: Search Results in Cardiology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Cardiology. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
31/12/69 - Venous thromboembolism, which includes deep-vein thrombosis and pulmonary embolism, is the third most common cause of vascular death after myocardial infarction and stroke. The mainstay of treatment is anticoagulation, and in patients without active cancer, guidelines suggest the use of direct oral…

Fractional Flow Reserve?Guided Multivessel Angioplasty in Myocardial Infarction
31/12/69 - Patients presenting with acute ST-segment elevation myocardial infarction (STEMI) are best treated with percutaneous coronary intervention (PCI) of the infarct-related coronary artery and the implantation of stents. Approximately 50% of these patients have additional, severe stenotic lesions in…

Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism
31/12/69 - Warfarin and direct oral anticoagulant agents prevent recurrent venous thromboembolism. When a first episode of venous thromboembolism occurs in association with a transient risk factor (e.g. surgery), treatment can be stopped after 3 months. With persistent and strong risk factors, such as cancer,…

Complete Revascularization in ST-Elevation Myocardial Infarction?
31/12/69 - Between 40 and 50% of patients who present with acute ST-elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Joint guidelines from the American College of Cardiology, the American Heart Association, and the European Society of Cardiology recommend treatment of the…

Under Pressure
31/12/69 - A 61-year-old man presents to the emergency department with shortness of breath and cough. Earlier that morning, he had sudden onset of dyspnea and tightness in his chest. The chest tightness had resolved, but he continued to feel short of breath. He reported no fevers but did have a productive cough.

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI
31/12/69 - Drug-eluting stents are the standard of care in percutaneous coronary intervention (PCI). Nevertheless, their rigid metallic cages hamper vasomotion, and they are associated with the development of neoatherosclerosis, which results in an ongoing risk of stent thrombosis (rate of 0.1 to 0.2% per…

Device Thrombosis with Bioresorbable Scaffolds
31/12/69 - The development of coronary-artery stents was a major advance in interventional cardiology. However, conventional stents, which are metallic, cage-like structures, have some limitations ? notably, they leave a permanent implant, which may prevent favorable arterial remodeling and preclude future…

Levosimendan for Hemodynamic Support after Cardiac Surgery
31/12/69 - Every year, more than 1 million patients undergo cardiac surgery in the United States and Europe. Acute perioperative left ventricular dysfunction is a major complication affecting up to 20% of such patients and is associated with increased mortality. Inotropic drugs (catecholamines and…

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
31/12/69 - Catheter ablation of atrial fibrillation is a well-established treatment for symptomatic atrial fibrillation. Guidelines have incorporated catheter ablation of symptomatic atrial fibrillation as a class 1 or 2 indication, depending on previous antiarrhythmic treatment and type of atrial…

Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery
31/12/69 - Cardiac surgery with the use of cardiopulmonary bypass is a common procedure, with more than 1 million operations performed annually in the United States and Europe. Increasingly, patients who are referred for cardiac surgery are older and have multiple coexisting conditions, as compared with those…

Copyright © 2004/2011 Health.Cat

Annuaire de Sante | S'inscrire au MedSante  | Dictionnaire medicale  Forumed des médecins